News-Yantai zhengfang pharmaceutical_Health Products

zhengfangyingxiao@qq.com

Scientific and technological innovation · People -oriented

NEWS

Is a modern pharmaceutical enterprises, mainly engaged in the treatment of diabetes, cardiovascular and cerebrovascular, liver disease, antiviral drugs and other research and development, production and sales.The company covers

Home page

Company News

Industry News

Mitiglinide Calcium Capsules The new version of the medical insurance catalog of clinical application advantages of analysis

Early-phase insulin secretion defect is a characteristic manifestation of abnormal insulin secretion pattern in type 2 diabetes mellitus patients, and insulinotropic agents have an important role in the treatment of type 2 diabetes mellitus. Coinciding with the successful entry of the new mealtime insulinotropic agent, Miglinide calcium, into the new version of the national health insurance catalog, Diabetes International invited Prof. Mou Yiming of the General Hospital of the Chinese People's Liberation Army to explain the advantages of the application and the applicable population of Miglinide calcium, and to analyze the benefits that will be provided to the patients after its entry into the health insurance.

18 Apr,2020

Explanation of pharmacological effects of Miglinide calcium in the new version of the medical insurance catalog

Defective β-cell insulin secretion is one of the central aspects of the pathogenesis of type 2 diabetes. Coinciding with the successful entry of the new mealtime insulinotropic agent, Miglinide calcium, into the new version of the National Health Insurance Catalog, Diabetes International invited Prof. Zhigang Zhao of the Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, to make a professional analysis of the advantages of the action of the new insulinotropic agent from the perspective of pharmacology.

18 Apr,2020

Effective reduction of postprandial hyperglycemia preferred medication - Miglinide calcium capsule

What's worse, the probability of diabetes is increasing among people under the age of 40, as well as pregnant women, and even primary and secondary school students in China.

21 Jan,2020

Golden single product, the heart and brain with treatment - Yixinone dispersible tablets

According to the World Health Organization: the number of people suffering from cardiovascular disease in China has reached 300 million, i.e. 2 out of every 10 adults suffer from cardiovascular disease.

21 Jan,2020

Pioglitazone is the preferred drug for the treatment of type 2 diabetes mellitus.

Diabetes mellitus is a disorder of sugar, fat and protein metabolism caused by a defect in insulin secretion or a decrease in the sensitivity of body tissues and cells to insulin. It is characterized by high blood glucose and is often characterized by excessive urination, drinking, eating and wasting, i.e. "three more and one less".

21 Jan,2020

Drug procurement "national first standard" came drug companies or face different situations

On November 15, the full text of the "4+7" Cities Drug Centralized Purchasing Document was published. With the consent of the Central Committee for Comprehensively Deepening Reform, the State organized a pilot centralized procurement of medicines, and the scope of the pilot area is Beijing, Tianjin, Shanghai, Chongqing, as well as Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu, Xi'an, and other 11 cities (referred to as the "4 + 7 cities"). According to the procurement documents, the first batch of banded procurement catalog totaled 31 varieties, including cefuroxime tablets, escitalopram oxalate tablets, and resuvastatin calcium tablets that have been full of three enterprises through consistency evaluation.

19 Nov,2018

Only two drugs have passed consistency evaluation in this $50 billion market

In 2017, the State Drug Administration issued the Guidelines for the Acceptance and Review of Consistency Evaluation of the Quality and Efficacy of Generic Drugs, thus kicking off the prelude to consistency evaluation. From the overall consistency evaluation through the situation, as of the end of August 2018, through (including deemed to pass) consistency evaluation of 98 specifications, involving 57 varieties, of which through (including deemed to pass) consistency evaluation of "289 varieties" specifications a total of 32, involving 18 varieties.

08 Oct,2018

Policy Interpretation of the Opinions on Improving the National Essential Drug System

I. What is the background and significance of the formulation and promulgation of the Opinions on Improving the National Essential Drug System (hereinafter referred to as the Opinions)?

20 Sep,2018

New changes in drug retailing are on the way

Two-ticket system, quality and efficacy consistency evaluation of generic drugs, reform of public hospitals, adjustment of medical insurance catalogue, hierarchical management of drugstores, reform of drug regulatory system and institutional reform...In 2018, these "hot words" constantly talked about by people in the drug retail industry reflect the strong correlation between the drug retail industry and the new medical reform, drug regulation and other policies.

06 Sep,2018

< 1 2 >